Ginkgo Bioworks is a synthetic biology company that engineers microbes for industrial applications across biopharma, agriculture, and industrial biotech. Through its Ferment Consortium, a $350 million investment vehicle, it funds and spins out new synthetic biology companies targeting established markets such as personal care, medicines, raw materials, and waste recovery.
85% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $89.9M (across 10 rounds with reported amounts).
Portfolio
11
Fund Size
$350M
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 WhiteLab Genomics | Seed | $10M | Sep 2022 |
 Turbine | Series A | — | Jan 2022 |
 Arcaea | Series A | $78M | Oct 2021 |
 Motif FoodWorks | Series B | $226M | Jun 2021 |
 Motif Foodworks | Series B | $226M | Jan 2021 |
 Culture Biosciences | Series B | $80M | Jan 2021 |
 AgBiome | Series D | $116M | Jan 2021 |
 Allonnia | Series A | $40M | Oct 2020 |
| AgBiome | Series C | $65M | Jul 2018 |
 Light Bio | Unknown | — | — |
 BiomEdit | Series A | $40M | — |
| BiomEdit | Series B | $18.4M | — |
 Verb Biotics | Seed | — | — |
Top Co-Investors
Viking Global Investors7 shared
General Atlantic3 shared
Wittington Ventures3 shared
CPT Capital2 shared
Louis Dreyfus Company2 shared
AiiM Partners2 shared
Breakthrough Energy Ventures2 shared
General Catalyst1 shared
NFX1 shared
Fonterra1 shared
Viking Global1 shared
CHANEL1 shared
Givaudan1 shared
ADM1 shared
Elevate Ventures1 shared
Betagro Ventures1 shared
Omnes Capital1 shared
Mercia Asset Management1 shared
Gates Foundation1 shared
Last updated: 7 October 2026